DONNA VUU: Open Payments
NPI 1245748979 · NEWPORT BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,107 in 47 payments from 13 companies in 2025. Trend: 2023 $3,517 · 2024 $2,380 · 2025 $1,107
Food & beverage: $1,107
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 18 | $462 |
| Regeneron Healthcare Solutions, Inc. | 3 | $99 |
| Amgen Inc. | 4 | $86 |
| Novartis Pharmaceuticals Corporation | 4 | $76 |
| Incyte Corporation | 3 | $68 |
| Janssen Biotech, Inc. | 3 | $66 |
| Fresenius Kabi USA, LLC | 2 | $47 |
| Lilly USA, LLC | 2 | $44 |
| UCB, Inc. | 1 | $42 |
| GENZYME CORPORATION | 2 | $35 |
Products named: NEMLUVIO, Otezla, DUPIXENT, OPZELURA, TREMFYA, LIBTAYO, COSENTYX, TALTZ.
Industry payments across CA — which companies pay providers there.
